Swiss Life Asset Management Ltd Buys 19,264 Shares of The Cooper Companies, Inc. $COO

Swiss Life Asset Management Ltd raised its stake in The Cooper Companies, Inc. (NASDAQ:COO) by 63.9% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 49,409 shares of the medical device company’s stock after acquiring an additional 19,264 shares during the quarter. Swiss Life Asset Management Ltd’s holdings in Cooper Companies were worth $3,387,000 at the end of the most recent reporting period.

Several other hedge funds have also recently bought and sold shares of COO. Buckhead Capital Management LLC boosted its stake in Cooper Companies by 14.3% in the 3rd quarter. Buckhead Capital Management LLC now owns 58,930 shares of the medical device company’s stock valued at $4,040,000 after purchasing an additional 7,368 shares during the period. First American Bank bought a new position in Cooper Companies during the 3rd quarter worth $1,646,000. Rakuten Investment Management Inc. acquired a new stake in shares of Cooper Companies during the third quarter worth $11,341,000. JANA Partners Management LP acquired a new stake in shares of Cooper Companies during the third quarter worth $166,917,000. Finally, Amundi boosted its position in shares of Cooper Companies by 35.5% in the second quarter. Amundi now owns 1,331,480 shares of the medical device company’s stock valued at $97,225,000 after acquiring an additional 348,652 shares during the period. 24.39% of the stock is currently owned by institutional investors and hedge funds.

Cooper Companies Stock Performance

Shares of NASDAQ:COO opened at $69.96 on Monday. The Cooper Companies, Inc. has a 1 year low of $61.78 and a 1 year high of $89.83. The stock has a market capitalization of $13.65 billion, a price-to-earnings ratio of 34.63, a price-to-earnings-growth ratio of 1.80 and a beta of 1.02. The company has a debt-to-equity ratio of 0.22, a current ratio of 1.34 and a quick ratio of 0.79. The company’s 50 day simple moving average is $79.97 and its 200 day simple moving average is $76.13.

Cooper Companies (NASDAQ:COO) last released its earnings results on Thursday, March 5th. The medical device company reported $1.10 earnings per share for the quarter, topping the consensus estimate of $1.03 by $0.07. Cooper Companies had a return on equity of 10.34% and a net margin of 9.67%.The firm had revenue of $1.02 billion during the quarter, compared to analysts’ expectations of $1.02 billion. During the same period in the prior year, the company earned $0.92 earnings per share. The company’s quarterly revenue was up 6.2% on a year-over-year basis. Cooper Companies has set its Q2 2026 guidance at 4.580-4.660 EPS. As a group, research analysts predict that The Cooper Companies, Inc. will post 3.98 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several research firms recently commented on COO. Barclays upped their price target on shares of Cooper Companies from $98.00 to $103.00 and gave the company an “overweight” rating in a research note on Friday, March 6th. Rothschild & Co Redburn downgraded shares of Cooper Companies from a “buy” rating to a “neutral” rating and set a $85.00 price objective for the company. in a report on Wednesday, March 4th. Wells Fargo & Company increased their target price on shares of Cooper Companies from $72.00 to $82.00 and gave the stock an “equal weight” rating in a research report on Friday, December 5th. Mizuho set a $100.00 target price on shares of Cooper Companies and gave the stock an “outperform” rating in a report on Friday, December 5th. Finally, The Goldman Sachs Group reiterated a “sell” rating and issued a $73.00 price target on shares of Cooper Companies in a research report on Friday, January 9th. One research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, seven have issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $90.79.

About Cooper Companies

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.